Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study K. SpargiasE. AdreanidesD. V. Cokkinos Clinical Trials 11 July 2006 Pages: 589 - 595
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes Mikiko ShimizuTsukasa UnoTomonori Tateishi Clinical Trials 17 June 2006 Pages: 597 - 603
Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients Giovanni TarantinoPaolo ConcaVincenzo Basile Pharmacodynamics 14 July 2006 Pages: 605 - 612
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study Dagmar BusseSilke TemplinKari T. Kivistö Pharmacodynamics 04 July 2006 Pages: 613 - 619
Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4 Ylva Böttiger Pharmacogenetics 22 June 2006 Pages: 621 - 625
Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios Yeomin YoonHyung-Doo ParkJunghan Song Pharmacogenetics 14 July 2006 Pages: 627 - 631
Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant L. Peter HackettKenneth F. IlettRolland Kohan Pharmacokinetics and Disposition 13 May 2006 Pages: 633 - 638
Effect of psychotropic medication on the in vitro metabolism of buprenorphine in human cDNA-expressed cytochrome P450 enzymes Stephanie BomsienRolf AderjanGisela Skopp Pharmacokinetics and Disposition 27 June 2006 Pages: 639 - 643
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone Aleksi TornioPertti J. NeuvonenJanne T. Backman Pharmacokinetics and Disposition 11 July 2006 Pages: 645 - 651
Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers Emmanuel KrupkaNicolas VenisseMarie-Christine Perault Pharmacokinetics and Disposition 11 July 2006 Pages: 653 - 659
Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies Tiina HeikkiläTuula LekanderHannu Raunio Pharmacoepidemiology and Prescription 22 June 2006 Pages: 661 - 665
Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Laurent AzoulayDriss OraichiAnick Bérard Pharmacoepidemiological and Prescription 22 June 2006 Pages: 667 - 674
Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives J. Lars G. NilssonGunnar LindbergArne Melander Pharmacoepidemiology and Prescription 06 July 2006 Pages: 675 - 680
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers M. JoergerT. M. BoschJ. H. M. Schellens Short Communication 24 June 2006 Pages: 681 - 684